期刊
EUROPEAN JOURNAL OF HEART FAILURE
卷 15, 期 12, 页码 1319-1326出版社
OXFORD UNIV PRESS
DOI: 10.1093/eurjhf/hft118
关键词
Vagal; Autonomic nervous system; Parasympathetic; Neurostimulation; Heart failure
资金
- Boston Scientific Corporation
- National Heart, Lung, and Blood Institute [PO1 HL074237-09]
Autonomic dysfunction is a feature of chronic heart failure (HF). This study tested the hypothesis that chronic open-loop electrical vagus nerve stimulation (VNS) improves LV structure and function in canines with chronic HF. Twenty-six canines with HF (EF 35) produced by intracoronary microembolizations were implanted with a bipolar cuff electrode around the right cervical vagus nerve and connected to an implantable pulse generator. The canines were enrolled in Control (n 7) vs. VNS therapy (n 7) or a crossover study, with crossovers occurring at 3 months (C VNS, n 6; VNS C, n 6). After 6 months of VNS, LVEF and LV end-systolic volume (ESV) were significantly improved compared with Control (EF Control 4.6 0.9 vs. VNS 6.0 1.6, P 0.001) and (ESV Control 8.3 1.8 mL vs. VNS 3.0 2.3 mL, P 0.002. Plasma and tissue biomarkers were also improved. In the crossover study, VNS also resulted in a significant improvement in EF and ESV compared with Control (EF Control 2.3 0.65 vs. VNS 6.7 1.1 mL, P 0.001 and ESV Control 3.2 1.2 mL vs. VNS 4.0 0.9 mL, P 0.001). Initiation of therapy in the Control group at 3 months resulted in a significant improvement in EF (Control 4.7 1.4 vs. VNS 3.7 0.74, P 0.001) and ESV (Control 1.5 1.2 mL vs. NS 5.5 1.6 mL, P 0.003) by 6 months. In canines with HF, long-term, open-looped low levels of VNS therapy improves LV systolic function, prevents progressive LV enlargement, and improves biomarkers of HF when compared with control animals that did not receive therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据